Table 4 Utilization of therapy according to ASCVD risk group.

From: Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population

 

ASCVD Risk

Therapy

≥ 20%

7.5-<20%

< 7.5%

All

n = 1,361

n = 2,924

n = 16,487

n = 20,772

More intensive

57.3

(780)

37.8

(1,108)

12.2

(2,015)

18.7

(3,903)

Less intensive

27.6

(376)

33.2

(973)

22.4

(3,694)

24.3

(5,043)

No therapy

15.1

(205)

28.8

(843)

65.4

(10,778)

56.9

(11,826)

  1. Detail of categorization for intensity of therapy is presented in Supplemental Materials and Supplemental.
Back to article page